{"registerEntryDetail":{"account":{"firstPublicationDate":"2022-03-02T09:21:47.000Z","registerNumber":"R002549"},"activity":{"code":"ACT_ORGANIZATION","de":"Unternehmen","en":"Company"},"activityDescription":"BioNTech wurde 2008 mit dem Verständnis gegründet, dass der Tumor jedes Krebspatienten einzigartig ist und die Behandlung jedes Patienten ebenso individualisiert erfolgen sollte. Um diese Idee in die Realität umzusetzen, hat BioNTech innovative Forschung mit modernen Technologien kombiniert. Das Ziel von BioNTech ist es, zukunftsweisende Therapien gegen Krebs und andere schwere Erkrankungen zu entwickeln. Während BioNTech daran arbeitet, den Nutzen unseres Behandlungsansatzes klinisch zu belegen, baut BioNTech kontinuierlich seine Kooperationen, sein Team und die eigenen Produktionsmöglichkeiten aus, um Patienten auf der ganzen Welt individualisierte Behandlungen anbieten zu können. Als deutsches Unternehmen mit Wurzeln in Mainz will BioNTech das weltweit führende Biotechnologieunternehmen für individualisierte Krebsmedizin werden. Seit der Zulassung seines Impfstoffs gegen COVID-19 im Dezember 2020 ist es die drängendste Aufgabe von BioNTech, einen Beitrag dafür zu leisten, dass möglichst viele Menschen einen Zugang zur COVID-19-Impfung bekommen.","activityOperationType":"BOTH","clientOrganizations":[{"address":{"city":"Mainz","country":"","nationalAdditional1":"BioNTech SE","street":"An der Goldgrube","streetNumber":"12","type":"NATIONAL","zipCode":"55131"},"legalRepresentatives":[{"commonFirstName":"Ugur","lastName":"Sahin","function":"Vorstand, Chief Executive Officer (CEO)","organizationMemberEmails":["info@biontech.de"],"phoneNumber":"+49613190840"},{"commonFirstName":"Sean","lastName":"Marett","function":"Vorstand, Chief Commercial Officer (CCO), Chief Business Officer (CBO)","organizationMemberEmails":["info@biontech.de"],"phoneNumber":"+49613190840"},{"commonFirstName":"Özlem","lastName":"Türeci","function":"Vorstand, Chief Medical Officer (CMO)","organizationMemberEmails":["info@biontech.de"],"phoneNumber":"+49613190840"},{"commonFirstName":"Sierk","lastName":"Poetting","function":"Vorstand, Chief Operating Officer (COO)","organizationMemberEmails":["info@biontech.de"],"phoneNumber":"+49613190840"},{"commonFirstName":"Ryan","lastName":"Richardson","function":"Vorstand, Chief Strategy Officer (CSO)","organizationMemberEmails":["info@biontech.de"],"phoneNumber":"+49613190840"},{"commonFirstName":"Jens","lastName":"Holstein","function":"Vorstand, Chief Financial Officer (CFO)","organizationMemberEmails":["info@biontech.de"],"phoneNumber":"+49613190840"}],"name":"BioNTech SE","organizationEmails":["info@biontech.de"],"phoneNumber":"+49613190840"}],"clientPersons":[],"codexViolation":false,"disclosureRequirementsExist":true,"donationInformationRequired":false,"donators":[],"employeeCount":{"from":1,"to":10},"fieldsOfInterest":[{"code":"FOI_HEALTH","de":"Gesundheit","en":"Health"},{"code":"FOI_HEALTH|FOI_HEALTH_MEDICINE","de":"Arzneimittel","en":"Medicine"},{"code":"FOI_SCIENCE_RESEARCH_TECHNOLOGY","de":"Wissenschaft, Forschung und Technologie","en":"Science, research and technology"}],"financialExpensesEuro":{"fiscalYearEnd":"12/21","fiscalYearStart":"01/21","from":190001,"to":200000},"id":4712,"legislativeProjects":[],"lobbyistIdentity":{"address":{"city":"Mainz","country":{"code":"DE"},"type":"NATIONAL"},"identity":"ORGANIZATION","legalForm":{"code":"LF_GMBH","code_de":"Gesellschaft mit beschränkter Haftung (GmbH)","code_en":"Limited liability company (GmbH)","type":"JURISTIC_PERSON"},"legalRepresentatives":[{"commonFirstName":"Sierk","function":"Managing Director (Geschäftsführer)","lastName":"Poetting","organizationMemberEmails":["info@biontech.de"],"phoneNumber":"+49613190840"},{"commonFirstName":"Michael","function":"Managing Director (Geschäftsführer)","lastName":"Böhler","organizationMemberEmails":["info@biontech.de"],"phoneNumber":"+49613190840"},{"commonFirstName":"Jan","function":"Managing Director (Geschäftsführer)","lastName":"Kürschner","organizationMemberEmails":["info@biontech.de"],"phoneNumber":"+49613190840"}],"membershipEntries":["Verband Forschender Arzneimittelhersteller e.V.","Freiwillige Selbstkontrolle für die Arzneimittelindustrie e.V. "],"name":"BioNTech Europe GmbH","namedEmployees":[{"commonFirstName":"Michael","lastName":"Bender"},{"commonFirstName":"Maritza","lastName":"Kompatzki"},{"commonFirstName":"Mike","lastName":"Schuster"}],"organizationEmails":["info@biontech.de"],"phoneNumber":"+49613190840","websites":["www.biontech.de"]},"refuseDonationInformation":false,"refuseFinancialExpensesInformation":false,"refusePublicAllowanceInformation":false,"registerEntryMedia":[{"media":{"fileName":"Verhaltenscodex-DE.pdf","mimeType":"application/pdf","url":"https://www.lobbyregister.bundestag.de/media/b4/b7/16361/Verhaltenscodex-DE.pdf"},"type":"CODE_OF_CONDUCT"},{"media":{"fileName":"BionTech-Konzern31-12-20-eBanz.pdf","mimeType":"application/pdf","url":"https://www.lobbyregister.bundestag.de/media/3c/82/16362/BionTech-Konzern31-12-20-eBanz.pdf"},"type":"ANNUAL_REPORT"}]},"registerNumber":"R002549","searchUrl":"https://www.lobbyregister.bundestag.de/suche/R002549/4712","source":"Deutscher Bundestag, Lobbyregister für die Interessenvertretung gegenüber dem Deutschen Bundestag und der Bundesregierung","sourceUrl":"https://www.lobbyregister.bundestag.de"}